home / stock / alny / alny articles

ALNY Articles, Alnylam Pharmaceuticals Inc. - From 07/18/24

Stock Information
Company Name: Alnylam Pharmaceuticals Inc.
Stock Symbol: ALNY
Market: NASDAQ
Website: alnylam.com
Menu
ALNY ALNY Quote ALNY Short ALNY News ALNY Articles ALNY Message Board
Get ALNY Alerts

News, Short Squeeze, Breakout and More Instantly...
$100 Invested In This Stock 20 Years Ago Would Be Worth $4,100 Today | Benzinga

Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 20 years by 12.59% on an annualized basis producing an average annu...
$100 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth This Much Today | Benzinga

Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 10 years by 4.95% on an annualized basis producing an average annua...

Rivian Automotive And Carvana Were Among The 10 Biggest Large Cap Gainers Last Week (June 23-June 29): Are These In Your Portfolio? | Benzinga

These ten large-cap stocks were the best performers in the last week. Are they in your portfolio? Rivian Automotive, Inc. (NASDAQ:RIVN) shares su...

Nvidia, Affirm Holdings, Carnival Corp, Alnylam Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today | Benzinga

On Monday, major U.S. indices showed mixed performance. The Dow Jones Industrial Average closed up by nearly 0.7% at 39,411.21, while the S&P 5...
Alnylam's Closely Watched Phase 3 Heart Disease Trial Of Vutrisiran Hits Primary Endpoint, Shares Surge | Benzinga

Monday, Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) revealed topline results from its HELIOS-B Phase 3 study of vutrisiran, an investigational RNAi t...

RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session | Benzinga

U.S. stock futures were mostly higher this morning, with the Dow futures gaining around 100 points on Monday. Shares of RXO, Inc.. (NYSE:RXO) share...

Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data | Benzinga

On Sunday, Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) presented results from the KARDIA-2 Phase 2 study, which evaluated the efficacy and...
$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today | Benzinga

Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 15 years by 1.97% on an annualized basis producing an average annua...

Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 15 Years | Benzinga

Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 15 years by 1.77% on an annualized basis producing an average annua...

Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension Challenges | Benzinga

Tuesday, Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) said the KARDIA-2 Phase 2 study of zilebesiran, an investigational RNAi therapeutic ta...
Previous 10 Next 10